Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Trivalent Influenza Vaccine in Kidney Transplant Recipients
NCT02104869Phase 4Completed
- Sponsor
- Instituto Butantan
- Start
- Apr 2014
- Primary completion
- Aug 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent influenza vaccine in influenza, sponsored by Instituto Butantan. Started Apr 2014; status: completed.
02
Drugs
trivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02104869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104869.